Inventor · disambiguated record
Burkhardt Laufer
Also filed as: LAUFER BURKHARDT
6 granted patents·10 pending applications·26 citations·filing 2007–2025
76Inventor score
Files withASCENDIS PHARMA AS8ASCENDIS PHARMA OPHTHALMOLOGY DIV A/S3ASCENDIS PHARMA ONCOLOGY DIV A/S2ASCENDIS PHARMA GROWTH DISORDERS DIV AS1MALLINCKRODT LLC1
Top patents by PatentIndex Score
16 records- 0186US8628750B2Cancer imaging and treatmentWESTER HANS JUERGEN·Filed 2007·Granted Jan 14, 2014·18 cites·19 claims
- 0279US11642415B2Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2019·Granted May 9, 2023·1 cites·28 claims
- 0374US12246070B2Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2023·Granted Mar 11, 2025·0 cites·4 claims
- 0473US10519226B2VEGF neutralizing prodrugs for the treatment of ocular conditionsASCENDIS PHARMA OPHTHALMOLOGY DIV A/S·Filed 2013·Granted Dec 31, 2019·6 cites·21 claims
- 0566US2023116809A1Prevention and treatment of ocular conditionsASCENDIS PHARMA OPHTHALMOLOGY DIV A/S·Filed 2022·Application pending·0 cites
- 0664US9855340B2Hydrogel prodrugsASCENDIS PHARMA AS·Filed 2013·Granted Jan 2, 2018·1 cites·44 claims
- 0763US2025255973A1Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2025·Application pending·0 cites
- 0851US2015010634A1Prevention and treatment of ocular conditionsASCENDIS PHARMA AS·Filed 2012·Application pending·0 cites
- 0951US2023340055A1Glycosylated il-2 proteins and uses thereofASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2021·Application pending·0 cites
- 1051US2016089446A1Modified HydrogelsASCENDIS PHARMA AS·Filed 2014·Application pending·0 cites
- 1150US11116849B2Hydrogel-linked prodrugs releasing tagged drugsASCENDIS PHARMA AS·Filed 2014·Granted Sep 14, 2021·0 cites·27 claims
- 1249US2025387503A1Drug conjugates for the treatment of ocular disordersASCENDIS PHARMA OPHTHALMOLOGY DIV A/S·Filed 2025·Application pending·0 cites
- 1347US2014100172A1Cancer Imaging and TreatmentMALLINCKRODT LLC·Filed 2013·Application pending·0 cites
- 1447US2017112939A1Prevention and treatment of ocular conditionsASCENDIS PHARMA GROWTH DISORDERS DIV AS·Filed 2017·Application pending·0 cites
- 1544US2021008168A1ConjugatesASCENDIS PHARMA AS·Filed 2019·Application pending·0 cites
- 1640US2022305136A1Anti-ctla4 conjugatesASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Burkhardt Laufer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →